These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38733953)

  • 1. Clinical outcomes with utilization of high-potency topical steroids in patients with lichen sclerosus-associated vulvar cancer.
    Vue NC; Sassani J; Prairie B; Yin Y; Krivak TC; Crafton S; Morse C; Nakayama J; Wield A; Horne ZD; Miller EM
    Gynecol Oncol; 2024 Aug; 187():58-63. PubMed ID: 38733953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of prescribing topical corticosteroids to patients with lichen sclerosus following surgery for vulvar cancer: a survey among gynaecologic oncologists in The Netherlands.
    Voss FO; Groenewegen KL; Vermaat H; Bleeker MCG; van Beurden M
    J Obstet Gynaecol; 2024 Dec; 44(1):2294330. PubMed ID: 38156715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does treatment of vulvar lichen sclerosus influence its prognosis?
    Cooper SM; Gao XH; Powell JJ; Wojnarowska F
    Arch Dermatol; 2004 Jun; 140(6):702-6. PubMed ID: 15210461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey on the use of topical steroids in patients treated for lichen sclerosus-associated vulval squamous cell carcinoma.
    Pounds R; Tahir S; Dawson C; Woodman C; Luesley D; Yap J
    J Obstet Gynaecol; 2018 Feb; 38(2):265-269. PubMed ID: 29017363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
    Funaro D; Lovett A; Leroux N; Powell J
    J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and adherence to topical corticosteroid therapy in women with vulvar lichen sclerosus: A retrospective cohort study.
    Kohn JR; Connors TM; Chan W; Liang CS; Dao H; Vyas A
    J Am Acad Dermatol; 2020 Oct; 83(4):1104-1109. PubMed ID: 32387654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical progesterone versus topical clobetasol propionate in patients with vulvar Lichen sclerosus - A double-blind randomized phase II pilot study.
    Günthert AR; Limacher A; Beltraminelli H; Krause E; Mueller MD; Trelle S; Bobos P; Jüni P
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():88-95. PubMed ID: 35290878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RF - Importance of Topical Corticosteroid Treatment for Vulvar Lichen Sclerosus to Prevent Recurrences of Vulvar Carcinoma.
    Luque-Luna M; Bosch-Amate X; Morgado-Carrasco D
    Actas Dermosifiliogr; 2022; 113(7):722-723. PubMed ID: 35461636
    [No Abstract]   [Full Text] [Related]  

  • 9. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease.
    Renaud-Vilmer C; Cavelier-Balloy B; Porcher R; Dubertret L
    Arch Dermatol; 2004 Jun; 140(6):709-12. PubMed ID: 15210462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbid Vulvar Lichen Sclerosus and High-Grade Squamous Intraepithelial Lesions: A Management Conundrum.
    Janke MJ; DeBlanc J; Kobernik EK; Skala SL; Hiles GL; Kelly R; Welch KC
    J Low Genit Tract Dis; 2022 Oct; 26(4):319-322. PubMed ID: 35972920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical interventions for genital lichen sclerosus.
    Chi CC; Kirtschig G; Baldo M; Brackenbury F; Lewis F; Wojnarowska F
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD008240. PubMed ID: 22161424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus.
    Bornstein J; Heifetz S; Kellner Y; Stolar Z; Abramovici H
    Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):80-4. PubMed ID: 9465808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of patients with vulvar lichen sclerosus and association to vulvar carcinoma: a retrospective single center analysis.
    Steinkasserer L; Hachenberg J; Hillemanns P; Jentschke M
    Arch Gynecol Obstet; 2023 Jun; 307(6):1921-1928. PubMed ID: 36409332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clobetasol propionate in the treatment of premenarchal vulvar lichen sclerosus.
    Smith YR; Quint EH
    Obstet Gynecol; 2001 Oct; 98(4):588-91. PubMed ID: 11576572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vulvar squamous cell hyperplasia and lichen sclerosus et atrophicus: clinical picture, morphology and treatment].
    Rotsztejn H; Krawczyk T; Bartodziej U
    Ginekol Pol; 1998 Feb; 69(2):67-72. PubMed ID: 9591383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma.
    Bleeker MC; Visser PJ; Overbeek LI; van Beurden M; Berkhof J
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1224-30. PubMed ID: 27257093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of vulvar lichen sclerosus and squamous cell hyperplasia to graduated topical steroids.
    Clark TJ; Etherington IJ; Luesley DM
    J Reprod Med; 1999 Nov; 44(11):958-62. PubMed ID: 10589407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring adherence to vulvar lichen sclerosus treatment - a prospective study.
    Zaino ML; Pixley JN; Subramanian VM; Sirdeshmukh D; Feldman SR; Pichardo RO
    J Dermatolog Treat; 2024 Dec; 35(1):2285725. PubMed ID: 38240095
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of Topical Corticosteroids With Reduced Vulvar Squamous Cell Carcinoma Recurrence in Patients With Vulvar Lichen Sclerosus.
    Chin S; Scurry J; Bradford J; Lee G; Fischer G
    JAMA Dermatol; 2020 Jul; 156(7):813-814. PubMed ID: 32374363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical Management of Penile and Urethral Lichen Sclerosus with Topical Clobetasol Improves Long-Term Voiding Symptoms and Quality of Life.
    Hayden JP; Boysen WR; Peterson AC
    J Urol; 2020 Dec; 204(6):1290-1295. PubMed ID: 32717158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.